Overview
2012Founded1
Compare with ELTEK LTD, Key Tronic or CTS CORP, or pick any stock.
- TickerNNDM on Nasdaq1
- Industryelectronics1
- HeadquartersWeizmann science park1
- Websitewww.nano-di.com
- Incorporated inIsrael4
- Business address60 Tower Road,, Waltham, Ma 024514
- Filer categoryAccelerated filer4
See how the biggest companies compare on our leaderboards
We innovate and provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials and consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.6 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
33.5%Gross margin7
-137.0%Operating margin7
-286.3%Net margin7
77.3%Revenue growth, 20257
-53.1%Return on equity7
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 78% of the revenue Nano Dimension Ltd. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Product | $47.2M | $45.6M | $80.4M |
| Service | $9.1M | $12.2M | $22.1M |
Regions
Americas brought in 44% of the revenue Nano Dimension Ltd. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Americas | $22.3M | $21.0M | $45.0M |
| EMEA | $31.0M | $33.4M | $40.7M |
| Asia Pacific | $2.9M | $3.4M | $16.7M |
| Israel | $900.0K | $200.0K | $400.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue65¢$68.1M
- Research and development29¢$30.1M
- Income tax7¢$7.2M
Out of $102.4M in revenue.7 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $102.4M | $57.8M | $56.3M |
| Total cost of revenue | $68.1M | $32.9M | $30.3M |
| Gross profit | $34.3M | $24.9M | $26.1M |
| Research and development | $30.1M | $39.6M | $65.1M |
| Sales and marketing | $35.7M | $27.7M | $34.3M |
| General and administrative | $59.8M | $46.0M | $56.0M |
| Restructuring costs | $7.6M | $0 | $0 |
| Desktop Metal litigation | $31.0M | $0 | $0 |
| Impairment losses | $10.5M | $1.3M | $0 |
| Operating loss | -$140.3M | -$89.6M | -$129.3M |
| (Loss) gain on investment in marketable equity securities | -$2.0M | -$52.3M | $23.5M |
| Other (expense) income, net | -$479.0K | $486.0K | $1.6M |
| Finance income | $35.4M | $42.6M | $47.6M |
| Finance expense | -$111.0K | -$668.0K | -$367.0K |
| Loss before income taxes | -$107.6M | -$99.5M | -$57.0M |
| Income tax expense | $7.2M | -$397.0K | -$62.0K |
| Net loss from continuing operations | -$100.4M | -$99.9M | -$57.1M |
| Net loss from discontinued operations, net of income tax of nil | -$193.3M | $0 | $0 |
| Net loss | -$293.6M | -$99.9M | -$57.1M |
| Less: Comprehensive loss attributable to non-controlling interests | -$323.0K | -$1.0M | -$1.1M |
| Net loss attributable to common shareholders | -$293.3M | -$98.8M | -$56.0M |
| Continuing operations - basic | -$0 | -$0 | -$0 |
| Continuing operations - diluted | -$0 | -$0 | -$0 |
| Discontinued operations - basic | -$1 | $0 | $0 |
| Discontinued operations - diluted | -$1 | $0 | $0 |
| Weighted Average Number of Shares Outstanding, Basic | 215.7K shares | 218.3K shares | 248.0K shares |
| Weighted Average Number of Shares Outstanding, Diluted | 215.7K shares | 218.3K shares | 248.0K shares |
| Foreign currency translation adjustment | $1.8M | -$1.9M | $2.4M |
| Remeasurement of pension and post-employment benefit plans, net of tax | $312.0K | -$2.8M | -$1.9M |
| Comprehensive loss | -$291.5M | -$104.6M | -$56.6M |
| Less: Comprehensive loss attributable to non-controlling interests | -$323.0K | -$1.1M | -$1.1M |
| Comprehensive loss attributable to common shareholders | -$291.2M | -$103.5M | -$55.5M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.7
| Period ending | 2025-12-31 | 2025-04-30 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $204.7M | $317.2M | |||
| Bank deposits | $169.0M | $440.8M | |||
| Marketable equity securities | $84.2M | $0 | |||
| Restricted bank deposits | $123.0K | $537.0K | |||
| Trade receivables, net of allowance for doubtful accounts ($861 and $811, respectively) | $26.0M | $9.1M | |||
| Other current assets | $8.9M | $4.8M | |||
| Inventory | $32.9M | $16.9M | |||
| Total current assets | $525.8M | $789.3M | |||
| Restricted bank deposits | $1.6M | $768.0K | |||
| Marketable equity securities | $0 | $86.2M | |||
| Property, plant and equipment, net | $24.8M | $14.1M | |||
| Operating lease right-of-use | $23.8M | $10.0M | |||
| Deferred tax assets | $424.0K | $0 | |||
| Goodwill | $40.4M | $40.4M | $0 | ||
| Intangible assets, net | $19.4M | $2.2M | |||
| Other assets | $1.9M | $0 | |||
| Total assets | $638.2M | $902.5M | |||
| Trade payables | $12.0M | $4.2M | |||
| Accrued liabilities | $19.5M | $18.8M | |||
| Deferred Revenue | $11.9M | $3.5M | |||
| Current portion of lease liability | $8.9M | $3.4M | |||
| Current portion of bank loan | $158.0K | $138.0K | |||
| Total current liabilities | $52.5M | $30.1M | |||
| Employee benefits | $3.7M | $4.7M | |||
| Operating lease right-of-use liabilities | $23.3M | $6.7M | |||
| Bank loan | $158.0K | $276.0K | |||
| Long-term settlement payable | $3.0M | $0 | |||
| Long-term deferred revenue | $3.6M | $0 | |||
| Total liabilities | $86.2M | $41.8M | |||
| Non-controlling interests | $0 | $715.0K | |||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 206,811,875 and 215,777,000 shares oustanding as of December 31, 2025 and December 31, 2024, respectively, and 279,306,522 and 273,847,185 shares issued as of December 31, 2025 and December 31, 2024, respectively. | $417.1M | $409.1M | |||
| Additional paid-in capital | $1.3B | $1.3B | |||
| Treasury stock | -$192.5M | -$167.7M | |||
| Accumulated other comprehensive income (loss) | $1.0M | -$1.1M | |||
| Accumulated Loss | -$971.0M | -$677.7M | |||
| Total equity attributable to common shareholders | $552.0M | $860.0M | |||
| Total equity | $552.0M | $860.8M | $1.0B | $1.2B | |
| Total liabilities and equity | $638.2M | $902.5M | |||
| Trade receivables, net of allowance for doubtful accounts | $861.0K | $811.0K | $660.0K |
| Period ending | 2025-12-31 | 2025-04-30 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $204.7M | $317.2M | |||
| Bank deposits | $169.0M | $440.8M | |||
| Marketable equity securities | $84.2M | $0 | |||
| Restricted bank deposits | $123.0K | $537.0K | |||
| Trade receivables, net of allowance for doubtful accounts ($861 and $811, respectively) | $26.0M | $9.1M | |||
| Other current assets | $8.9M | $4.8M | |||
| Inventory | $32.9M | $16.9M | |||
| Total current assets | $525.8M | $789.3M | |||
| Restricted bank deposits | $1.6M | $768.0K | |||
| Marketable equity securities | $0 | $86.2M | |||
| Property, plant and equipment, net | $24.8M | $14.1M | |||
| Operating lease right-of-use | $23.8M | $10.0M | |||
| Deferred tax assets | $424.0K | $0 | |||
| Goodwill | $40.4M | $40.4M | $0 | ||
| Intangible assets, net | $19.4M | $2.2M | |||
| Other assets | $1.9M | $0 | |||
| Total assets | $638.2M | $902.5M | |||
| Trade payables | $12.0M | $4.2M | |||
| Accrued liabilities | $19.5M | $18.8M | |||
| Deferred Revenue | $11.9M | $3.5M | |||
| Current portion of lease liability | $8.9M | $3.4M | |||
| Current portion of bank loan | $158.0K | $138.0K | |||
| Total current liabilities | $52.5M | $30.1M | |||
| Employee benefits | $3.7M | $4.7M | |||
| Operating lease right-of-use liabilities | $23.3M | $6.7M | |||
| Bank loan | $158.0K | $276.0K | |||
| Long-term settlement payable | $3.0M | $0 | |||
| Long-term deferred revenue | $3.6M | $0 | |||
| Total liabilities | $86.2M | $41.8M | |||
| Non-controlling interests | $0 | $715.0K | |||
| Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 206,811,875 and 215,777,000 shares oustanding as of December 31, 2025 and December 31, 2024, respectively, and 279,306,522 and 273,847,185 shares issued as of December 31, 2025 and December 31, 2024, respectively. | $417.1M | $409.1M | |||
| Additional paid-in capital | $1.3B | $1.3B | |||
| Treasury stock | -$192.5M | -$167.7M | |||
| Accumulated other comprehensive income (loss) | $1.0M | -$1.1M | |||
| Accumulated Loss | -$971.0M | -$677.7M | |||
| Total equity attributable to common shareholders | $552.0M | $860.0M | |||
| Total equity | $552.0M | $860.8M | $1.0B | $1.2B | |
| Total liabilities and equity | $638.2M | $902.5M | |||
| Trade receivables, net of allowance for doubtful accounts | $861.0K | $811.0K | $660.0K |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net loss from continuing operations | -$100.4M | -$99.9M | -$57.1M |
| Depreciation, amortization and non-cash lease interest | $20.5M | $2.6M | $2.0M |
| Impairment losses | $10.5M | $1.4M | $326.0K |
| Changes in fair value of equity securities | $2.0M | $52.3M | -$23.5M |
| Loss from deconsolidation of subsidiaries | $1.7M | $0 | $0 |
| Share-based compensation expense | $4.9M | $15.7M | $22.1M |
| Decrease (increase) in inventory | $5.6M | $387.0K | -$340.0K |
| (Increase) decrease in other current assets | -$175.0K | $6.1M | -$5.8M |
| (Increase) decrease in trade receivables | -$1.5M | $3.0M | -$5.6M |
| Increase in deferred tax assets | -$7.5M | $0 | -$11.0K |
| (Decrease) increase in other payables | -$10.0M | -$1.1M | $4.9M |
| (Decrease) increase in employee benefits | -$1.4M | -$562.0K | -$1.5M |
| Increase in trade payables | $6.9M | $47.0K | $1.1M |
| Other | -$1.4M | $1.2M | -$5.3M |
| Net cash used in operating activities | -$70.3M | -$18.9M | -$68.7M |
| Change in bank deposits | $270.8M | $100.5M | -$189.1M |
| Purchase of property plant and equipment | -$1.1M | -$2.2M | -$9.1M |
| Acquisition of intangible asset | $0 | -$711.0K | -$1.5M |
| Acquisition of subsidiaries, net of cash acquired | -$267.8M | $0 | $0 |
| Deconsolidation of subsidiaries | -$476.0K | $0 | $0 |
| Other | $0 | $0 | $835.0K |
| Net cash from (used in) investing activities | $1.4M | $97.6M | -$198.8M |
| Repayment long-term bank debt | -$149.0K | -$180.0K | -$536.0K |
| Proceeds from Noncontrolling Interests | $0 | $555.0K | $1.1M |
| Payment of a liability for contingent consideration in a business combination | $0 | $0 | -$9.3M |
| Payments of share price protection recognized in business combination | $0 | -$363.0K | -$4.5M |
| Repurchase of treasury shares | -$24.9M | -$69.8M | -$96.4M |
| Net cash used in financing activities | -$25.0M | -$69.7M | -$109.5M |
| Net cash used in operating activities | -$31.0M | $0 | $0 |
| Net cash used in investing activities | -$437.0K | $0 | $0 |
| Net cash provided by financing activities | $10.0M | $0 | $0 |
| Net cash used in discontinued operations | -$21.4M | $0 | $0 |
| (Decrease) increase in cash, cash equivalents and restricted cash | -$115.3M | $9.0M | -$377.1M |
| Effect of exchange rate fluctuations on cash | $3.2M | -$997.0K | $1.3M |
| Intangible Asset Acquired On Credit | $0 | $0 | $711.0K |
| Property plant and equipment acquired on credit | $17.0K | $69.0K | $214.0K |
| Lease liabilities arising from obtaining right-of-use assets | $1.2M | $1.3M | $929.0K |
| Acquisition Replacement Awards For Pre Combination Service | $2.1M | $0 | $0 |
| Income taxes paid during the year | $115.0K | $314.0K | $136.0K |
No quarter-by-quarter statement was filed.
Corporate structure
Nano Dimension Ltd. sits at the top of its group. 52 entities, 18 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Nano Dimension Ltd.
- TANG CAPITAL MANAGEMENT LLC Filed SCHEDULE 13G on Nano Dimension Ltd., latest Aug 21, 2026 (3 filings since Jun 30, 2026)
- Oramed Pharmaceuticals Filed SCHEDULE 13D/A on Nano Dimension Ltd., latest Jul 22, 2026 (4 filings since Jan 29, 2026)
- Murchinson Ltd. Filed SCHEDULE 13D/A on Nano Dimension Ltd., latest Jul 20, 2026 (18 filings since Jan 23, 2023)
- Anson Funds Management LP Filed SCHEDULE 13D/A on Nano Dimension Ltd., latest Jul 14, 2025 (7 filings since Mar 10, 2023)
- Yoav Stern Filed SC 13D/A on Nano Dimension Ltd., latest Dec 14, 2021
- Nano Dimension Ltd. Weizmann science park
- Stratasys Stake · Eden Prairie
- A.I.D.R.O. Srl Subsidiary · Italy
- Adaptive 3D Technologies, LLC Subsidiary · Texas, United States
- Adaptive3D LLC Subsidiary · Delaware, United States
- addLEAP AB Subsidiary · Sweden
- Admatec Europe B.V. Subsidiary · Netherlands
- Beacon Bio, Inc. Subsidiary · Delaware, United States
- Brewer Tafla Dental Technologies, LLC Subsidiary · Oklahoma, United States
- Dental Arts Laboratories, Inc. Subsidiary · Illinois, United States
- Desktop Labs, Inc. Subsidiary · Delaware, United States
- Desktop Metal Inc. Subsidiary · Delaware, United States
- Desktop Metal Operating, Inc. Subsidiary · Delaware, United States
- Desktop Metal Securities Corporation Subsidiary · Massachusetts, United States
- Desktop Metal Taiwan Branch Office Subsidiary · Taiwan
- DM Belgium B.V. Subsidiary · Belgium
- Envisiontec GmbH Subsidiary · Germany
- EnvisionTec Group Canada, Inc. Subsidiary · Canada
- EnvisionTEC US LLC Subsidiary · Delaware, United States
- Essemtec AG Subsidiary · Switzerland
- Essemtec Deutschland GmbH Subsidiary · Germany
- Essemtec France SAS Subsidiary · France
- Essemtec USA, LLC Subsidiary · Delaware, United States
- ExOne Americas, LLC Subsidiary · Delaware, United States
- ExOne GmbH Subsidiary · Germany
- ExOne Operating, LLC Subsidiary · Delaware, United States
- and 26 more
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.
What it owns
What Nano Dimension Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $60.4M7 Dec 31, 2025 | $38.7M7 Dec 31, 2024 | +56.1% |
| Accumulated depreciation | $35.6M7 Dec 31, 2025 | $24.6M7 Dec 31, 2024 | +44.9% |
| Property and equipment, net | $24.8M7 Dec 31, 2025 | $14.1M7 Dec 31, 2024 | +75.6% |
| Operating-lease assets (leased space) | $23.8M7 Dec 31, 2025 | $10.0M7 Dec 31, 2024 | +138.9% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $204.7M7 Dec 31, 2025 | $317.2M7 Dec 31, 2024 | −35.5% |
| Marketable securities, non-current | $07 Dec 31, 2025 | $86.2M7 Dec 31, 2024 | −100.0% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $40.4M7 Dec 31, 2025 | $07 Dec 31, 2024 | |
| Finite-lived intangibles, gross | $22.4M7 Dec 31, 2025 | $2.2M7 Dec 31, 2024 | +903.4% |
| Accumulated amortization | -$3.0M7 Dec 31, 2025 | -$80.0K7 Dec 31, 2024 | −3641.2% |
| Finite-lived intangibles, net | $19.4M7 Dec 31, 2025 | $2.2M7 Dec 31, 2024 | +801.8% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $32.9M7 Dec 31, 2025 | $16.9M7 Dec 31, 2024 | +94.6% |
| Raw materials | $10.7M7 Dec 31, 2025 | $9.0M7 Dec 31, 2024 | +18.7% |
| Work in process | $3.8M7 Dec 31, 2025 | $1.7M7 Dec 31, 2024 | +118.7% |
| Finished goods | $18.4M7 Dec 31, 2025 | $6.2M7 Dec 31, 2024 | +198.1% |
Properties, in its own words
Our corporate headquarters are in Waltham, Massachusetts in an approximately 128,000 square foot facility located at 60 Tower
Road, Waltham, Massachusetts. The lease of this facility expires on September 30, 2031. The total monthly base rent payment for the facilities in Waltham is currently approximately $433,000. We lease a 46,000 square foot manufacturing facility at 4 Suburban Park Drive, Billerica, Massachusetts which expires in October 2029. Our research and development facility, manufacturing facility and in-house laboratory are located at Ilan Ramon 2, and Ilan Ramon 6, Ness Ziona, Israel, where we currently lease altogether approximately 54,000 square feet. In addition, we have offices in Germany, Switzerland, UK, Sweden, and Poland. We own a 35,000 square feet building in Aesch, Switzerland utilized by Essemtec for both production and administration offices.
Item 2 of the 10-K filed Mar 31, 2026.6
Leadership
Who has led Nano Dimension Ltd., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
201520202025
- Chief executive officerDavid Stehlin May 29, 2026 to Aug 24, 202615
- Chief executive officerMoshe H. Rozenbaum Aug 24, 2026 to now16
- Chief financial officerJohn Brenton May 29, 2026 to now17
Board members and other officers (9)
- Board memberDavid Stehlin May 29, 2026 to now15
- Board memberPhillip Borenstein May 29, 2026 to now18
- Board memberRobert M. Pons May 29, 2026 to now19
- Board memberJoshua Rosensweig Jun 2, 2026 to now20
- Board memberAndrew Sriubas Jun 4, 2026 to now21
- Board memberEliezer Eli Tarlow Aug 24, 2026 to now22
- Board memberMoshe H. Rozenbaum Aug 24, 2026 to now16
- Board memberPinchos Fruchthandler Aug 24, 2026 to now23
- Board memberNadav Kidron Aug 25, 2026 to now24
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- A.I.D.R.O. Srl Italy5
- Adaptive 3D Technologies, LLC Texas5
- Adaptive3D LLC Delaware5
- Admatec Europe B.V. Netherlands5
- Beacon Bio, Inc. Delaware5
- Brewer Tafla Dental Technologies, LLC Oklahoma5
- DM Belgium B.V. Belgium5
- Dental Arts Laboratories, Inc. Illinois5
- Desktop Labs, Inc. Delaware5
- Desktop Metal Inc. Delaware5
- Desktop Metal Operating, Inc. Delaware5
- Desktop Metal Securities Corporation Massachusetts5
- Desktop Metal Taiwan Branch Office Taiwan5
- EnvisionTEC US LLC Delaware5
- EnvisionTec Group Canada, Inc. Canada5
- Envisiontec GmbH Germany5
- Essemtec AG Switzerland5
- Essemtec Deutschland GmbH Germany5
- Essemtec France SAS France5
- Essemtec USA, LLC Delaware5
- ExOne Americas, LLC Delaware5
- ExOne GmbH Germany5
- ExOne KK Japan5
- ExOne Operating, LLC Delaware5
All 52 listed subsidiaries
- Figur Machine Tools LLC New Jersey5
- Formatec Holding B.V. Netherlands5
- Formatec Technical Ceramics B.V. Netherlands5
- Global Inkjet Systems Ltd. United Kingdom5
- H.K. Rep. Office Hong Kong5
- Jetted Additively Manufactured Electronics Sources GmbH Germany5
- Larry Brewer Dental Lab, Inc. Oklahoma5
- MKFG Israel Israel5
- MKFG Poland, sp. z.o.o Poland5
- MKFG Teton Simulation, LLC Wyoming5
- MarkForged Holding Corporation Delaware5
- MarkForged, Inc. Delaware5
- Markforged Canada 3D Printing Inc. Canada5
- Markforged Ireland Services 3D Printing Limited Ireland5
- Markforged Japan 3D Printing K.K. Japan5
- Markforged Sweden, A.B. Sweden5
- May Dental Arts, LLC Missouri5
- Meta Additive Ltd. United Kingdom5
- Nano Dimension (HK) Limited Hong Kong5
- Nano Dimension Australia Pty Ltd. Australia5
- Nano Dimension GmbH Germany5
- Nano Dimension NY Ltd. New York5
- Nano Dimension Swiss GmbH Switzerland5
- Nano Dimension Technologies Ltd. Israel5
- Nano Dimension Trading (Shenzhen) Ltd. China5
- Nano Dimension USA Inc. Delaware5
- Syzygy Memory Plastics Corporation Delaware5
- addLEAP AB Sweden5
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Oct 2, 20268-K Change of auditor25
- Aug 24, 2026New chief executive Moshe H. Rozenbaum becomes CEO16
- Aug 18, 20268-K Executive or director change; Regulation FD disclosure26
- Aug 6, 20268-K Results of operations27
- Jul 21, 20268-K Other events28
- Jul 21, 20268-K Entered a material agreement; Change in control; Executive or director change29
- Jun 17, 20268-K Regulation FD disclosure30
- Jun 15, 20268-K Regulation FD disclosure31
- Jun 11, 20268-K Other events32
- May 29, 2026New chief executive David Stehlin becomes CEO15
- May 27, 20268-K Other events33
- May 26, 20268-K Regulation FD disclosure34
- May 7, 20268-K Results of operations35
- Apr 30, 20268-K Other events36
- Feb 2016Went public Listed on NASDAQ1
- 2012Founded Founded1
Calendar
Coming up
- Nov 18, 2026Reports results for the quarter ending Sep/202637
When it reported results
- Aug 6, 2026Reported quarterly or annual results27
- May 7, 2026Reported quarterly or annual results35
- Mar 31, 2026Reported quarterly or annual results38
- Jan 21, 2026Reported quarterly or annual results39
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
379 filings to the SEC since October 2021: 5 annual reports, 2 quarterly reports, 16 major events, 20 insider forms, 33 large holders, 303 other. The latest 20:
- Oct 2, 20268-K EDGAR
- Sep 17, 2026144 EDGAR
- Sep 15, 2026144 EDGAR
- Sep 15, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 25, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 25, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 24, 20263 OWNERSHIP DOCUMENT EDGAR
- Aug 21, 2026SCHEDULE 13G EDGAR
- Aug 18, 20268-K EDGAR
- Aug 7, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 27, 2026SCHEDULE 13D/A EDGAR
- Jul 22, 2026SCHEDULE 13D/A EDGAR
- Jul 21, 20268-K EDGAR
- Jul 21, 20268-K EDGAR
- Jul 21, 2026DFAN14A EDGAR
- Jul 20, 2026SCHEDULE 13D/A EDGAR
- Jul 16, 2026DFAN14A EDGAR
The 379 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- TANG CAPITAL MANAGEMENT LLCSCHEDULE 13G, 3 filings Jun 30, 2026 to Aug 21, 202640
- Oramed PharmaceuticalsSCHEDULE 13D/A, 4 filings Jan 29, 2026 to Jul 22, 202641
- Murchinson Ltd.SCHEDULE 13D/A, 18 filings Jan 23, 2023 to Jul 20, 202642
- Anson Funds Management LPSCHEDULE 13D/A, 7 filings Mar 10, 2023 to Jul 14, 202543
- Yoav SternSC 13D/A, 1 filing Dec 14, 202144
Stakes it holds
Nano Dimension Ltd. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Murchinson Ltd. | 18,836,276 | $27.3M | 13.4% | +3,286,276 |
| Tang Capital Management LLC | 14,292,813 | $20.7M | 0.9% | New |
| Boothbay Fund Management, LLC | 9,418,138 | $13.7M | 0.3% | +1,643,138 |
| Man Group plc | 3,347,937 | $4.9M | 0.0% | −1,140,763 |
| Marshall Wace, Llp | 3,136,735 | $4.5M | 0.0% | New |
| Millennium Management LLC | 2,537,950 | $3.7M | 0.0% | +905,418 |
| Two Sigma Investments, LP | 2,285,332 | $3.3M | 0.0% | −242,558 |
| Susquehanna International Group, Llp | 1,751,432 | $2.5M | 0.0% | −225,843 |
| Peapod Lane Capital LLC | 1,451,728 | $2.1M | 1.4% | −308,815 |
| ARK Investment Management LLC | 1,247,498 | $1.8M | 0.0% | −168,620 |
| Gem Investment Advisors, LLC | 1,000,000 | $1.4M | 0.9% | New |
| Mitsubishi UFJ Asset Management Co., Ltd. | 757,725 | $1.1M | 0.0% | +194,030 |
| UBS Group AG | 741,274 | $1.1M | 0.0% | +4,836 |
| Morgan Stanley | 706,237 | $1.0M | 0.0% | −914,829 |
| Tidal Investments LLC | 674,642 | $978.2K | 0.0% | +419,208 |
| Caption Management, LLC | 475,000 | $688.8K | 0.0% | New |
| State Street Corp | 472,575 | $685.2K | 0.0% | −9,896,848 |
| Steel Partners Holdings L.P. | 469,377 | $680.6K | 0.9% | New |
| Quadrature Capital Ltd | 232,298 | $336.8K | 0.0% | New |
| MYDA Advisors LLC | 210,251 | $304.9K | 0.1% | New |
| Marquette Asset Management, LLC | 199,356 | $289.1K | 0.0% | New |
| LPL Financial LLC | 184,305 | $267.2K | 0.0% | −34,077 |
| Geode Capital Management, LLC | 173,788 | $252.0K | 0.0% | No change |
| XTX Topco Ltd | 146,893 | $213.0K | 0.0% | +136,500 |
| Susquehanna Fundamental Investments, LLC | 126,012 | $182.7K | 0.0% | No change |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Nano Dimension Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARNano Dimension Ltd.2
- CIK0001643303
- Employer ID (EIN)52-00291096
- Filer statusAccelerated filer not an emerging growth company; not a smaller reporting company; not a shell company6
- Incorporated inIsrael6
- Fiscal year endsDecember 312
- Industry code (SIC)3672 Printed Circuit Boards2
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance2
- Business address60 Tower Road,, Waltham, MA 024512
- Phone972 54 62444652
- Shares outstanding210,839,011 as of Aug 5, 202613
- Public float$353.3M as of Jun 30, 20256
- AuditorKPMG LLP, Stamford, Connecticut PCAOB ID 185; it also attests to the company’s internal control over financial reporting6
- On EDGAR sinceJun 8, 20152
- Filings765 in all: 6-K (438), 144 (53), SC 13D/A (31), SC TO-T/A (19), CORRESP (17), 8-K (16), 424B5 (14), SC 13G (14)2
All 51 form types
SC 13G/A (12), DFAN14A (11), UPLOAD (11), 20-F (10), 3 (10), 4 (10), EFFECT (9), SCHEDULE 13D/A (9), DEFA14A (7), F-1/A (7), F-3 (6), 6-K/A (5), 20FR12B/A (4), SC 13D (4), 424B4 (3), 8-A12B (3), F-1 (3), F-3ASR (3), S-8 (3), SC TO-C (3), 10-Q (2), 425 (2), DEFC14A (2), F-1MEF (2), F-3MEF (2), PREC14A (2), SCHEDULE 13D (2), 10-K (1), 144/A (1), 20FR12B (1), CERTNAS (1), CT ORDER (1), D (1), DRS (1), DRS/A (1), DRSLTR (1), F-6 (1), FWP (1), NT 10-K (1), NT 20-F (1), RW (1), SC TO-T (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (10-K) Mar 31, 2026
Quarterly report (10-Q) Aug 7, 2026
Latest 8-K (8-K) Oct 2, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| American Depositary Shares | NNDM | Nasdaq |
| Rights to Purchase American Depositary Shares | NNDM | Nasdaq |
From the cover page of the 10-K filed Mar 31, 2026 (Section 12(b) of the Exchange Act).6
Risk factors and legal proceedings
The risks Nano Dimension Ltd. names in Item 1A of its 10-K filed Mar 31, 2026: 40 risks under these headings, as written.6
- Risks Related to Our Business and Industry
- Risks Related to Our Financial Condition and Capital Requirements
- Risks Related to Our Intellectual Property
- Risks Related to the Ownership of the ADSs or our Ordinary Shares
- Risks Related to Israeli Law and Our Operations in Israel
- General Risk Factors
- Our strategic shift away from acquiring businesses towards a focus on the evaluation of a comprehensive range of strategic alternatives and improving our core business and executing its implementation may be unsuccessful.
- Our re-domestication from Israel to the United States may adversely affect shareholders and subject us to new legal, tax and regulatory risks.
- The U.S. trade tariffs may increase the costs of importing our products into the U.S. and increase our supply chain costs which could potentially reduce profit margins and affect our competitive position.
- We are subject to particular risks in light of our Interim National Security Agreements with the U.S. Government.
- Our operating results and financial condition may fluctuate.
- The markets in which we participate are competitive. Our failure to compete successfully could cause any future revenues and the demand for our products not to materialize or to decline over time.
The other 34 risks
- Defects in products could give rise to product returns or product liability, warranty or other claims that could result in material expenses, diversion of management time and attention, and damage to our reputation.
- As the regulatory framework for AI technology evolves, our business, financial condition, and results of operations may be adversely affected.
- If our relationships with suppliers for our products and services, especially with single source suppliers of components of our products, were to terminate or our manufacturing arrangements were to be disrupted, our business could be interrupted.
- A change in operations at our manufacturing sites and operations of our third-party service providers, such as discontinuation or disruption, could prevent us from timely filling customer orders and could lead to unforeseen costs for us.
- Under applicable employment laws, we may not be able to enforce covenants not to compete and therefore may be unable to prevent our competitors from benefiting from the expertise of some of our former employees.
- We are subject to environmental laws due to the import and export of our products, which could subject us to compliance costs and/or potential liability in the event of non-compliance.
- Recent changes in personnel and management may disrupt our operations and adversely affect our business.
- Shareholder activism could disrupt our business and adversely affect our strategic direction.
- Although we generate revenues from the sale of our current products, we may never be profitable.
- Previous mergers and acquisitions resulted in acquiring businesses that themselves were operating at a financial loss; and we may be unable to effectively mitigate those losses through post-merger integration and/or additional cost reductions measures and/or divestments.
- Our non-financial assets may lead to significant impairments in the future.
- We maintain our cash at financial institutions, some in balances that exceed federally insured limits.
- Failure to prevail in lawsuits in which we are involved may result in a reduction in our capital reserves and divert management attention.
- Lack of patent protection may hinder our market competitiveness and failure to safeguard trade secrets could enable competition to use our proprietary information.
- Inability to maintain effective proprietary rights for our products, may affect our ability to compete effectively.
- Third-party claims of intellectual property infringement may prevent or delay our development and commercialization efforts.
- We may be involved in lawsuits to protect or enforce our intellectual property, which could be expensive, time consuming, and unsuccessful.
- We may not be able to protect our intellectual property rights throughout the world.
- We do not anticipate paying any dividends, except as related to the repurchase of our Ordinary Shares as provided under the Companies Law.
- We may be a “passive foreign investment company”, or PFIC, for U.S. federal income tax purposes in 2025 or in any subsequent taxable year. There generally would be adverse tax consequences for U.S. taxpayers that are holders of our ADSs or Ordinary Shares if we are or were to become a PFIC.
- ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable results to the plaintiff(s) in any such action.
- ADS holders may not have the same rights as the holders of our Ordinary Shares.
- ADS holders may not receive the same distributions or dividends as those we make to the holders of our Ordinary Shares, and, in some limited circumstances, they may not receive dividends or other distributions on our Ordinary Shares and they may not receive any value for them, if it is illegal or impractical to make them available to ADS holders.
- The market price of our ADSs has been, and may continue to be, highly volatile, and such volatility could cause the market price of our ADSs to decrease and could cause you to lose some or all of your investment in our ADSs.
- Short sales or hedging transactions involving the ADSs may cause the price of the ADSs to decline.
- As some of our offices, manufacturing facilities, and third-party contract manufacturers are located in Israel, we may be adversely affected by the implications of political, economic and military instability in Israel.
- Provisions of Israeli law, and our amended and restated articles of association delay, prevent or otherwise impede a merger with, or an acquisition of, our company, which could prevent a change of control, even when the terms of such a transaction are favorable to us and our shareholders.
- Our operations are subject to currency rate fluctuations.
- We received Israeli government grants for certain of our research and development activities. The terms of those grants may require us to pay royalties and to satisfy specified conditions in order to manufacture products and transfer technologies outside of Israel. If we fail to satisfy these conditions, we may be required to pay penalties and refund grants previously received.
- Inflation could adversely affect our business and results of operations.
- Your rights and responsibilities as a shareholder will be governed by Israeli law, which differs in some material respects from the rights and responsibilities of shareholders of U.S. companies.
- Raising additional capital would cause dilution to holders of our securities and may affect the rights of existing shareholders and ADS holders.
- Significant disruptions to our information technology systems or breaches of our data security could adversely affect our business.
- If securities or industry analysts do not publish or cease publishing research or reports about us, our business or our market, or if they adversely change their recommendations or publish negative reports regarding our business or our ADSs or Ordinary Shares, the price and trading volume of our ADSs or Ordinary Shares could decline.
Legal proceedings
From time to time, we may become a party to various litigation matters incidental to the conduct of our business. Except as disclosed below, we are not presently party to any legal proceedings the resolution of which we believe would have a material adverse effect on our business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels.
The opening of Item 3, Legal Proceedings.6
Links
- Websitewww.nano-di.com1
- WikidataQ65251731
- SEC EDGARCIK 1643303
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataNano Dimension Ltd. on Wikidata
- 2
- 3Yahoo FinanceNNDM quote
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18SEC EDGARPhillip Borenstein, Board member
- 19SEC EDGARRobert M. Pons, Board member
- 20SEC EDGARJoshua Rosensweig, Board member
- 21SEC EDGARAndrew Sriubas, Board member
- 22SEC EDGAREliezer Eli Tarlow, Board member
- 23SEC EDGARPinchos Fruchthandler, Board member
- 24SEC EDGARNadav Kidron, Board member
- 25SEC EDGARChange of auditor
- 26
- 27SEC EDGARResults of operations
- 28SEC EDGAROther events
- 29
- 30SEC EDGARRegulation FD disclosure
- 31SEC EDGARRegulation FD disclosure
- 32SEC EDGAROther events
- 33SEC EDGAROther events
- 34SEC EDGARRegulation FD disclosure
- 35SEC EDGARResults of operations
- 36SEC EDGAROther events
- 37NasdaqNasdaq calendar
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45